Cargando…

LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis

BACKGROUND: Recent studies have revealed that dysregulated expression of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (lncRNA NNT-AS1) is associated with cell tumorigenicity in non-small cell lung cancer. However, the exact molecular mechanisms of NNT-AS1 in lung squa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jing, Qi, Guanbin, Li, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257167/ https://www.ncbi.nlm.nih.gov/pubmed/32514270 http://dx.doi.org/10.1186/s11658-020-00227-8

Ejemplares similares

LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
por: Liu, Yanjie, et al.
Publicado: (2020)

LncRNA NNT‐AS1 promotes non‐small cell lung cancer progression through regulating miR‐22‐3p/YAP1 axis
por: He, Wenlong, et al.
Publicado: (2020)

Antisense lncRNA NNT-AS1 promoted esophageal squamous cell carcinoma progression by regulating its sense gene NNT expression
por: Pan, Xianglong, et al.
Publicado: (2022)

LncRNA GACAT3 promotes esophageal squamous cell carcinoma progression through regulation of miR-149/FOXM1
por: Su, Min, et al.
Publicado: (2021)

LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis
por: Qi, Guanbin, et al.
Publicado: (2020)

LncRNA SNHG1 Regulates the Progression of Esophageal Squamous Cell Cancer by the miR-204/HOXC8 Axis
por: Li, Hao Miao, et al.
Publicado: (2020)

Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis
por: Lu, Ye-Bin, et al.
Publicado: (2017)

EGR1 modulated LncRNA HNF1A-AS1 drives glioblastoma progression via miR-22-3p/ENO1 axis
por: Ma, Chunchun, et al.
Publicado: (2021)

LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis
por: Sun, Bo, et al.
Publicado: (2021)

LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis
por: Zhu, Huaqiang, et al.
Publicado: (2020)

LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis
por: Wu, Dianchao, et al.
Publicado: (2020)

Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma
por: Sun, Qiang, et al.
Publicado: (2021)

LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression
por: Liu, Shihai, et al.
Publicado: (2019)

NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis
por: Yao, Changlei, et al.
Publicado: (2020)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis
por: Li, Hongle, et al.
Publicado: (2020)

Silencing lncRNA AFAP1-AS1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma Cells via Regulating the miR-498/VEGFA Axis
por: Shen, Wenhao, et al.
Publicado: (2020)

Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis
por: Wu, Tianyi, et al.
Publicado: (2016)

LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis
por: Fu, Su-Wei, et al.
Publicado: (2020)

LncRNA PITPNA‐AS1/miR‐223‐3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma
por: Peng, Bi‐hao, et al.
Publicado: (2022)

Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
por: Hu, Tao, et al.
Publicado: (2022)

LncRNA NNT-AS1 regulates proliferation, ECM accumulation and inflammation of human mesangial cells induced by high glucose through miR-214-5p/smad4
por: Geng, Zhuang, et al.
Publicado: (2021)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

LncRNA NEAT1 Knockdown Inhibits Retinoblastoma Progression by miR-3619-5p/LASP1 Axis
por: Chen, Xuedong, et al.
Publicado: (2020)

lncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis
por: Ji, Yuan Yuan, et al.
Publicado: (2020)

LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
por: Liang, Yiran, et al.
Publicado: (2020)

LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis
por: Zhou, Lili, et al.
Publicado: (2021)

LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis
por: Han, Gang, et al.
Publicado: (2021)

LncRNA MSC-AS1 Promotes Colorectal Cancer Progression by Regulating miR-325/TRIM14 Axis
por: He, Changhong, et al.
Publicado: (2021)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis: NORAD promotes myocardial infarction via miR-22-3p/PTEN
por: Li, Chunxia, et al.
Publicado: (2022)

Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma
por: Wu, Tianyi, et al.
Publicado: (2021)

NFIB-Mediated lncRNA PVT1 Aggravates Laryngeal Squamous Cell Carcinoma Progression via the miR-1301-3p/MBNL1 Axis
por: Tang, Tian, et al.
Publicado: (2021)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis [Corrigendum]
Publicado: (2021)

lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1
por: Gao, Yongsheng, et al.
Publicado: (2022)

LncRNA‐HOTAIR promotes endothelial cell pyroptosis by regulating the miR‐22/NLRP3 axis in hyperuricaemia
por: Chi, Kun, et al.
Publicado: (2021)

LncRNA‐HOTAIR promotes endothelial cell pyroptosis by regulating the miR‐22/NLRP3 axis in hyperuricemia
Publicado: (2023)

LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis
por: Tang, Jianwei, et al.
Publicado: (2021)

lncRNA MNX1-AS1 promotes prostate cancer progression through regulating miR-2113/MDM2 axis
por: Liang, Dong, et al.
Publicado: (2022)

LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis
por: Ding, Yuqin, et al.
Publicado: (2023)

lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR-495-3p/MYCBP axis
por: Qian, Jiajie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5tnjgo9cu4eenetl4bq9fil9ar